February 26, 2026 08:59 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'CBFC didn't apply mind': Kerala High Court stays Kerala Story 2 release | Operation Sindoor 2.0 will be stronger if India forced to launch: Top Army commander warns Pakistan | ‘Heads must roll!’ Supreme Court cracks down on NCERT textbook over judiciary chapter | ‘1.2 crore voters may be dropped’: Mamata Banerjee flags major concern over SIR list | India-US trade deal at risk? Trump imposes massive 126% duty on solar imports | ‘My life reflects this reality’: Shooter Tara Shahdeo recalls forced conversion amid Kerala Story 2 row | Modi begins Israel visit to boost defence, tech and strategic ties | Trump claims Pakistan PM told him he prevented 35 million deaths by stopping India-Pakistan conflict | Supreme Court's big move over Bengal SIR! Odisha, Jharkhand judicial officers allowed to complete revision process | ‘Kerala lives in harmony, film’s portrayal wrong’: Kerala High Court raps Kerala Story sequel makers
Adar Poonawalla
Image Credit: Adar Poonawalla Twitter

Serum Insititute chief Adar Poonwalla to get 'Y-category' security cover

| @indiablooms | Apr 29, 2021, at 02:26 am

New Delhi/IBNS: Pune-based Serum Institute of India's chief Adar Poonawalla will be provided with 'Y-category' security across the country, media reports said.

The order was issued by the Union Home Ministry following an assessment of the threats received by Poonawalla.

"Y category" security means he will be covered by 11 security personnel, out of which one or two of them will be commandos and the rest policemen.

Serum Institute came under heavy criticism after it announced the pricing of its Covishield vaccine to the states for the 18 to 45 age group at Rs. 400 a shot, which is way above the Rs.150 price offered to the Centre.

The revised pricing has provoked anger among many and opposition leaders as well as social media users have demanded "One vaccine one price".

On Wednesday, the Serum Institute announced a 25 per cent reduction in price for the states and will now offer Covishiled at Rs. 300 instead of Rs. 400.

"As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives," Poonawalla tweeted.
 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.